Making People Better
Dr. Andrés G. Fernández. Ferrer Advanced Biotherapeutics, Director
Address: Avda. Diagonal 549; 5th floor
City: 08029. Barcelona
Province: Barcelona
Phone: 34 936.003.700
Fax: 34 934.914.720
Mission and Objectives
FERRER is a private pharmaceutical group that works for the wellbeing of society through the promotion of health.
FERRER has a direct presence in 26 countries and its products are present in more than 90 territories.
FERRER is characterized by the diversification of its business covering drug prescription, vaccines, molecular diagnostics, OTC and food additives.
FERRER maintains a high investment in R&D of new therapies and diagnostics.
Products/Services, Areas of interest for future collaborations/Alliances
FERRER is currently active in the clinical development of new drugs in spinal cord injury, infectious diseases and sleep disorders. It also develops projects under the "polypill" concept, as the recently launched TRINOMIA, to facilitate treatment compliance and the rationalization of costs for the health systems.
Ferrer Advanced Biotherapeutics (FAB), the Biotech Research Division of Ferrer Internacional, identifies, promotes and develops therapeutic and diagnostic projects in collaboration with external groups. Projects, based on cutting-edge technology platforms, provide high added value solutions in fields such as CNS, cardiovascular, oncology, dermatology, ophthalmology and gastroenterology.EPICUP, a new cancer of unknown primary diagnostics system based on epigenetic markers is the first product fully developed by FAB.

Developed by Web4Bio